Prevention of Metabolic Syndrome in Serious Mental Illness

Rohan Ganguli; Martin Strassnig

doi:10.1016/j.psc.2010.11.004

Prevention of Metabolic Syndrome in Serious Mental Illness

Rohan Ganguli, Martin Strassnig

Psychiatry & Behavioral Sciences

Research output: Contribution to journal › Review article › peer-review

15 Scopus citations

Abstract

The interaction of lifestyle, socioeconomic status, genetic factors, and treatment with antipsychotic medications likely accounts for the high risk of metabolic syndrome, diabetes, heart disease, and premature mortality in people with serious mental illness. Given the high risk of developing diabetes and cardiovascular disease in persons with serious mental illness, psychiatrists who treat these individuals need to ensure they are familiar with these risks, monitor metabolic parameters in their patients, and educate their patients (and caregivers) about the risks and how to prevent them.

Original language	English (US)
Pages (from-to)	109-125
Number of pages	17
Journal	Psychiatric Clinics of North America
Volume	34
Issue number	1
DOIs	https://doi.org/10.1016/j.psc.2010.11.004
State	Published - Mar 2011

Keywords

Antipsychotic medication
Lifestyle management
Mental illness
Metabolic syndrome

ASJC Scopus subject areas

Psychiatry and Mental health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.psc.2010.11.004

Cite this

@article{3d492d8863724f06a120cee061a1a2b1,

title = "Prevention of Metabolic Syndrome in Serious Mental Illness",

abstract = "The interaction of lifestyle, socioeconomic status, genetic factors, and treatment with antipsychotic medications likely accounts for the high risk of metabolic syndrome, diabetes, heart disease, and premature mortality in people with serious mental illness. Given the high risk of developing diabetes and cardiovascular disease in persons with serious mental illness, psychiatrists who treat these individuals need to ensure they are familiar with these risks, monitor metabolic parameters in their patients, and educate their patients (and caregivers) about the risks and how to prevent them.",

keywords = "Antipsychotic medication, Lifestyle management, Mental illness, Metabolic syndrome",

author = "Rohan Ganguli and Martin Strassnig",

note = "Funding Information: This work was partially supported by a Canadian Institutes of Health Research (CIHR) Tier 1 Canada Research Chair grant to Dr Ganguli, and a 2008 Young Investigator Award to Dr Martin Strassnig, from the National Alliance for Research in Schizophrenia and Depression (NARSAD) . ",

year = "2011",

month = mar,

doi = "10.1016/j.psc.2010.11.004",

language = "English (US)",

volume = "34",

pages = "109--125",

journal = "Psychiatric Clinics of North America",

issn = "0193-953X",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Prevention of Metabolic Syndrome in Serious Mental Illness

AU - Ganguli, Rohan

AU - Strassnig, Martin

N1 - Funding Information: This work was partially supported by a Canadian Institutes of Health Research (CIHR) Tier 1 Canada Research Chair grant to Dr Ganguli, and a 2008 Young Investigator Award to Dr Martin Strassnig, from the National Alliance for Research in Schizophrenia and Depression (NARSAD) .

PY - 2011/3

Y1 - 2011/3

N2 - The interaction of lifestyle, socioeconomic status, genetic factors, and treatment with antipsychotic medications likely accounts for the high risk of metabolic syndrome, diabetes, heart disease, and premature mortality in people with serious mental illness. Given the high risk of developing diabetes and cardiovascular disease in persons with serious mental illness, psychiatrists who treat these individuals need to ensure they are familiar with these risks, monitor metabolic parameters in their patients, and educate their patients (and caregivers) about the risks and how to prevent them.

AB - The interaction of lifestyle, socioeconomic status, genetic factors, and treatment with antipsychotic medications likely accounts for the high risk of metabolic syndrome, diabetes, heart disease, and premature mortality in people with serious mental illness. Given the high risk of developing diabetes and cardiovascular disease in persons with serious mental illness, psychiatrists who treat these individuals need to ensure they are familiar with these risks, monitor metabolic parameters in their patients, and educate their patients (and caregivers) about the risks and how to prevent them.

KW - Antipsychotic medication

KW - Lifestyle management

KW - Mental illness

KW - Metabolic syndrome

UR - http://www.scopus.com/inward/record.url?scp=79951564154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951564154&partnerID=8YFLogxK

U2 - 10.1016/j.psc.2010.11.004

DO - 10.1016/j.psc.2010.11.004

M3 - Review article

C2 - 21333843

AN - SCOPUS:79951564154

VL - 34

SP - 109

EP - 125

JO - Psychiatric Clinics of North America

JF - Psychiatric Clinics of North America

SN - 0193-953X

IS - 1

ER -

Prevention of Metabolic Syndrome in Serious Mental Illness

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this